Vimarsana
Biggest News Aggregation in the World

Page 5 - Gregory Bailey News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gregory Bailey. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gregory Bailey Today - Breaking & Trending Today

Piper Sandler Boosts Biohaven (NYSE:BHVN) Price Target to $36.00 - Vimarsana News

Piper Sandler Boosts Biohaven (NYSE:BHVN) Price Target to $36.00

Biohaven (NYSE:BHVN – Free Report) had its price target upped by Piper Sandler from $29.00 to $36.00 in a report issued on Wednesday, Benzinga reports. Piper Sandler currently has an overweight rating on the stock. Separately, JPMorgan Chase & Co. cut their target price on shares of Biohaven from $27.00 to $24.00 and set an […]

Source: wkrb13.com
Biohaven (NYSE:BHVN) Hits New 12-Month High at $29.99 - Vimarsana News

Biohaven (NYSE:BHVN) Hits New 12-Month High at $29.99

Biohaven Ltd. (NYSE:BHVN – Get Free Report) shares hit a new 52-week high on Thursday . The stock traded as high as $29.99 and last traded at $29.20, with a volume of 53542 shares traded. The stock had previously closed at $29.49. Analyst Upgrades and Downgrades Separately, JPMorgan Chase & Co. cut their price objective […]

City of Roanoke police arrest report - Vimarsana News

City of Roanoke police arrest report

Period ending October 23rd

Gregory Bailey Buys 17,817 Shares of Biohaven Ltd. (NYSE:BHVN) Stock - Vimarsana News

Gregory Bailey Buys 17,817 Shares of Biohaven Ltd. (NYSE:BHVN) Stock

Biohaven Ltd. (NYSE:BHVN – Get Free Report) Director Gregory Bailey bought 17,817 shares of the company’s stock in a transaction that occurred on Wednesday, October 4th. The shares were purchased at an average cost of $22.57 per share, for a total transaction of $402,129.69. Following the acquisition, the director now owns 1,525,788 shares of the […]

Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement - Vimarsana News

Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement

Merger to result in NYSE American-listed company focused on developing therapeutics based on Serina’s proprietary POZ Platform™ delivery technology Lead program of the combined company will...